🚨Postdoc position open at @BarcelonaBeta🚨 We're looking someone to work on a project at the intersection of cardiovascular and neurodegenerative research 🫀🧠 Fully funded position!!! More details: www.imim.cat/media/upload... Please share! #Alzheimer's #ENDALZ

🚨Paper alert🚨 New publication in JAMA Neurology led by @gsalvado.bsky.social. In a multicentric study, we examined the clinical utility to assess preclinical #Alzheimer’s disease in cognitively unimpaired individuals. jamanetwork.com/journals/jam... A 🧵...

🚨New publication in Nature Medicine! In this study, we demonstrate that a brief, self-administered cognitive test battery can reliably identify individuals with cognitive impairment in a primary care setting. More details: linkedin.com/feed/update/... Full paper: www.nature.com/articles/s41...

New paper published today in @nataging.nature.com ! This one took some time but it's always a pleasure working hand in hand with Laia Montoliu-Gaya and the Gothenburg team. Thanks also to the McGill group for also collaborating with TRIAD data. A 🧵 below. #ENDALZ

Very grateful to have had the opportunity to share our work comparing the FDA-approved p-tau217/AB42 blood test to CSF!

‼️NEW PREPRINT‼️ What if you could take a normal 3T T1w MRI and make it look like it was acquired from a 7T scanner? That's exactly what we do using AI in our new preprint! Link: arxiv.org/abs/2507.13782 #neuroskyence #neurosky #compneuro #AI #datascience #neurology #mrisky #neuroimaging

New manuscript alert! Are plasma biomarkers🩸 predictive of Alzheimer’s disease progression in Down Syndrome (DS)? Our new study in collaboration with the ABC-DS consortium has now been published in @thelancetneuro.bsky.social: www.thelancet.com/journals/lan...

✨ REMINDER!! ✨ please help me gather the most inspiring papers of the last year (including your own!!) by completing the survey below! 🙏 Looking so much forward to presenting the @NeuroimagingPIA year in review talk at #AIC2025 in Toronto this July!! 🤩 alz.surveymonkey.com/r/923BTQK

How does the brain reorganize in the context of age and AD? Are functional changes in age and AD similar? Are these changes dynamic across the age/AD spectrum? We unpack these questions in a sample of N=973 with AD biomarkers Preprint: tinyurl.com/ymv8s7h8 ⬇️🧵 1/

🚨New paper in Alzheimer's & Dementia! We investigate whether p-tau immuno-assays selectively quantifying low-molecular-weight (LMW) tau (CNS) are more specific for tau changes in AD vs ALS than assays not differentiating between LMW and high-MW (PNS) tau👇https://pubmed.ncbi.nlm.nih.gov/40289884/

The preprint of my first PhD project is live! 🧠 Find the link to the manuscript and read about the key findings below. 👇 #alzheimersdisease #neuroimaging #tau #amyloid #mri #pet #biofinder

A new, simpler and cheaper analytical method for the early detection of #Alzheimers disease could help bring #blood tests into the #healthcare system globally, according to a new study co-authored by @noellewarmenhoven.bsky.social from 🇸🇪 @lund-university.bsky.social.

New manuscript alert! Can blood-based biomarkers measured on a fully automated platform accurately identify Alzheimer’s disease (AD) pathology?🩸 Our new multi-cohort study has now been published in @naturemedicine.bsky.social: nature.com/articles/s41.... A thread🧵

‼️New publication on a novel plasma biomarker for tau pathology 🧠🧪 in @naturemedicine.bsky.social led by Kanta Horie & @gsalvado.bsky.social: 📖 www.nature.com/articles/s41... In this study, we investigated plasma eMTBR-tau243, which closely reflects tau tangle pathology in Alzheimer’s disease (AD).